Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABAL.L Regulatory News (ABAL)

  • There is currently no data for ABAL

Directorate Change

3 Jan 2012 07:00

RNS Number : 8402U
Imaginatik PLC
03 January 2012
Β 

ο»Ώ

3 January 2012

Imaginatik plc

("Imaginatik" or the "Company")

Β 

Directorate Change

Β 

Imaginatik plc (AIM: IMTK), a leading provider of enterprise innovation solutions including a range of technology products and consultancy, is pleased to announce the appointment of Nick Goss to the Board of the Company as Chief Technology Officer with immediate effect.

Β 

His management experience includes numerous technology leadership positions across several medium-sized businesses in the EU and the US which has enabled him to build core business strengths in areas such as growth strategy formulation and implementation, turnaround execution, and assisting businesses in transitioning to online, Cloud and SaaS based delivery models.

Β 

Prior to joining Imaginatik, Mr Goss had spent 10 years in the US, most recently as owner of Polardene Corporation, a boutique SaaS, Cloud and Online Services Consultancy for software companies in transition. Polardene identifies target customers' preferences for clients thereby enabling them to invest effectively in product development. Other previous experience includes Chief Information Officer at DestinyUSA, where he oversaw the development and deployment of new revenue and sustainability models. He was also Senior Director at BMC Software, a systems and service management software company for enterprise customers where he led the turnaround of the SaaS and managed services business unit by transitioning to a new delivery platform and eliminating loss-making services.

Β 

Earlier in his career, Mr. Goss held senior positions at Digica Limited, the onshore and offshore IT outsourcer, and at DCS plc, a logistics software, supply chain and ERP solutions provider.

Β 

Imaginatik also announces the resignation of Mr. Andrew Wainwright from the Board as Chief Technology Officer, effective immediately. The Board thanks him for his valued contribution and wishes him well in the future.

Β 

Matt Cooper, Executive Chairman of Imaginatik, commented, "We welcome Nick to the Board of Imaginatik, he will be a valuable addition to the team, responsible for leading the technical and development functions. As we continue to develop our business, Nick's experience in product management and his technology and industry background will be highly valuable in helping drive the company forward."

Β 

For the purposes of paragraph (g) of Schedule 2 of the AIM rules, the following information is disclosed:

Β 

Full name: Nicholas John Goss

Β 

Age: 51

Β 

Current directorships

Past directorships (within last five years)

Polardene Corporation

None

Β 

Mr. Goss has confirmed that there is no further information to be disclosed.

Β 

For further information please contact:

Β 

Imaginatik plc

Tel: 020 7917 2975

Matt Cooper, Executive Chairman / Shawn Taylor, CFO

Northland Capital Partners Limited

Tel: 020 7796 8800

Gavin Burnell / Edward Hutton

Threadneedle Communications

Tel: 020 7653 9850

Caroline Evans-Jones / Hilary Millar

Β 

Β 

About Imaginatik

Β 

Imaginatik provides Innovation and Idea management solutions comprised of consultancy, enterprise software and program management to deliver innovation results to companies such as The World Bank, NYSE, The Chubb Group of Insurance Companies, Boeing, Pfizer, Goodyear, Paccar, Kellogg and Cargill. Few companies possess the internal capability to consistently generate fresh ideas, identify those worth pursuing and reliably transform them into real, value-enhancing assets. This is Imaginatik's area of expertise.

Β 

Imaginatik is a public company whose shares are traded on the AIM market of the London Stock Exchange (LSE:IMTK.L) and is a World Economic Forum Technology Pioneer with offices in Boston, MA, and Winchester, UK. For more information visit www.imaginatik.com.

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
BOABKBDNFBKDDDK
Date   Source Headline
27th Sep 20187:30 amRNSSuspension - Imaginatik plc
26th Sep 20187:00 amRNSUpdate on potential equity investment
17th Sep 20187:00 amRNSUpdate on potential equity investment
11th Sep 201811:35 amRNSUpdate regarding Nominated Adviser
11th Sep 20187:00 amRNSFinal Results
4th Sep 20187:00 amRNSUpdate on potential equity investment
29th Aug 20189:22 amRNSHolding(s) in Company
28th Aug 20189:12 amRNSHolding(s) in Company
24th Aug 20183:39 pmRNSHolding(s) in Company
17th Aug 20183:40 pmRNSIssue of Equity
26th Jul 20187:00 amRNSNew Finance Agreement
25th Jul 20181:05 pmRNSStmnt re Share Price Movement
10th Jul 20184:56 pmRNSHolding(s) in Company
10th Jul 20189:48 amRNSHolding(s) in Company
10th Jul 20187:00 amRNSAppointment of CEO
3rd Jul 20185:45 pmRNSHolding(s) in Company
3rd Jul 20187:00 amRNSIssue of Equity
29th Jun 201810:46 amRNSResult of General Meeting and Total Voting Rights
22nd Jun 20187:00 amRNSContract Win
18th Jun 201812:59 pmRNSHolding(s) in Company
15th Jun 20187:00 amRNSRelease of mobile update to Innovation Central
14th Jun 20187:00 amRNSPosting of circular and notice of general meeting
5th Jun 20185:40 pmRNSHolding(s) in Company
5th Jun 20187:00 amRNSResult of strategic review and new funding
29th May 20187:00 amRNSUpdate on sales process and funding
1st May 20187:00 amRNSTrading Statement
21st Mar 20187:00 amRNSUpdate on strategic review and formal sale process
14th Feb 201812:38 pmRNSForm 8.3 - [Imaginatik plc]
12th Feb 20185:51 pmRNSForm 8.3 - Imaginatik plc
9th Feb 20185:50 pmRNSForm 8.3 - Imaginatik
9th Feb 20185:48 pmRNSForm 8.3 - Imaginatik
8th Feb 20183:36 pmRNSHolding(s) in Company
1st Feb 20183:04 pmRNSForm 8 (DD) - Imaginatik plc
1st Feb 201811:36 amRNSForm 8.3 - Imaginatik PLC
1st Feb 20187:00 amRNSForm 8 (OPD) - Imaginatik plc
1st Feb 20187:00 amRNSStrategic review including formal sale process
7th Dec 20177:00 amRNSHalf-year Report
29th Sep 20177:00 amRNSGrant of Options
27th Sep 20177:00 amRNSContract Win
20th Sep 20179:37 amRNSHolding(s) in Company
7th Sep 20175:50 pmRNSResult of AGM
15th Aug 20178:00 amRNSNotice of AGM
7th Aug 20177:00 amRNSFinal Results
10th Jul 201710:47 amRNSHolding(s) in Company
5th Jul 20174:32 pmRNSHolding(s) in Company
4th Jul 20179:51 amRNSHolding(s) in Company
4th Jul 20177:00 amRNSHolding(s) in Company
3rd Jul 201711:10 amRNSResult of Open Offer and Total Voting Rights
27th Jun 20177:00 amRNSResult of GM and Total Voting Rights
9th Jun 20171:04 pmRNSPlacing and Open Offer to raise up to £1.9 million

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.